Found 57 matching trials
Bioequivalence and Adhesion of a Rotigotine Patch in Healthy Subjects PHASE1 This study was intended to demonstrate bioequivalence of the Amarin's Rotig...
Show More Location
Cliantha Research Ltd.
Learn More & Join Trial
Trial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal Patch PHASE3 The purpose of this study is to show Rotigotine dose response at four doses...
Show More Location
Multiple Locations
Learn More & Join Trial
A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease Patients PHASE2 Safety of SPM 962 in a once-daily repeated long-term treatment in Parkinson...
Show More Location
Multiple Locations
Learn More & Join Trial
A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis PHASE3 This is a sleep laboratory study to evaluate the efficacy and safety of Rot...
Show More Learn More & Join Trial
Bioequivalence Study of Rotigotine Transdermal Patch With Two Different Formulations in Healthy Japanese Subjects PHASE1 To investigate and compare the drug amount delivered to the body after each...
Show More Learn More & Join Trial
A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's Disease PHASE4 The purpose of this study is to assess the safety and feasibility of switch...
Show More Learn More & Join Trial
Study in Healthy Volunteers to Prove That Two Rotigotine Patches From Different Manufacturing Sites Deliver Equivalent Drug Amount to the Body PHASE1 The major aim of this study is to investigate and compare the drug amount d...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Assess Pharmacokinetic Profiles of LY03003 and Neupro PHASE1 Phase 1, single center study to assess pharmacokinetic profiles of rotigoti...
Show More Location
Pharmaron CPC, Inc.
Learn More & Join Trial
A Dose-ranging Study for SPM 962 in Parkinson's Disease Patients PHASE2 The primary objective of this trial is to establish the maximum maintenance...
Show More Location
Multiple Locations
Learn More & Join Trial
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine PHASE3 The objective of this trial is to assess the effects of transdermal rotigot...
Show More Location
Multiple Locations
Learn More & Join Trial